Medications

Expanded recall of warfarin level monitoring test strips

(HealthDay)—Certain lots of Roche Diagnostics test strips should not be used with CoaguChek test meter devices to check levels of the blood thinner warfarin because patients may get inaccurate results and be at risk for ...

Other

Roche buys US Foundation Medicine for $2.4 bn

Swiss pharmaceutical giant Roche said Tuesday it had reached an agreement to purchase the remaining shares of US lab Foundation Medicine, of which it already holds a majority stake, for $2.4 billion.

Medications

Roche seals takeover of cancer data upstart Flatiron

Swiss pharmaceutical giant Roche on Friday said it has completed its acquisition of US oncology data leader Flatiron Health, a tech upstart that has runs a huge platform of cancer patient records.

Oncology & Cancer

Roche targets tumours with Ignyta purchase

Roche, the world's top cancer drug maker, announced Friday it had agreed to buy US firm Ignyta, which is developing a treatment against some tumours, for $1.7 billion (1.4 billion euros).

Oncology & Cancer

FDA gives green light to Roche cancer test

The US Food and Drug Administration has given the green light to Roche for its FoundationOne CDx personalised diagnostic cancer test, the Swiss group said Monday.

Other

Roche taking majority in Foundation Medicine for $1.03B

Roche is taking a majority stake in U.S.-based Foundation Medicine in a deal worth $1.03 billion that the Swiss pharmaceutical company says will help it to develop new treatment options for cancer patients.

Diseases, Conditions, Syndromes

US gives go-ahead to fast Ebola test

US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.

page 3 from 7